ConductScience.org, home

Paper26328915

The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma.

Chen SB and 6 others. J Cancer Res Clin Oncol, 2016. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma. Papers, record 26328915. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26328915

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
2016
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2025-07-19
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen SBShao-bin
2Weng HRHong-rui
3Wang GGeng
4Liu DTDi-tian
5Li HHua
6Zhang HHao
7Chen YPYu-ping

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Esophageal NeoplasmsMajor topic
EsophagectomyMajor topic
Neoplasm Recurrence, LocalMajor topic
Radiotherapy, AdjuvantMajor topic
Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Staging
Prognosis
Retrospective Studies
Survival Rate

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123749498Adjuvant radiation therapy and lymphadenectomy in esophageal cancer: a SEER database analysis.J Gastrointest Surg2013https://conductscience.org/library/papers/23749498PubMed
29054879Reevaluation of postoperative radiotherapy for thoracic esophageal carcinoma.Int J Radiat Oncol Biol Phys1997https://conductscience.org/library/papers/9054879PubMed
39776161The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer.Am J Surg1998https://conductscience.org/library/papers/9776161PubMed
412517291Three-field dissection for squamous cell carcinoma in the thoracic esophagus.Ann Thorac Cardiovasc Surg2002https://conductscience.org/library/papers/12517291PubMed
512607634Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients.Ann Thorac Surg2003https://conductscience.org/library/papers/12607634PubMed
620667325Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus.Ann Thorac Surg2010https://conductscience.org/library/papers/20667325PubMed
718640307Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.Ann Thorac Surg2008https://conductscience.org/library/papers/18640307PubMed
821296855Global cancer statistics.CA Cancer J Clin2011https://conductscience.org/library/papers/21296855PubMed
97639004Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study.World J Surg1995https://conductscience.org/library/papers/7639004PubMed
1023773390Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma.Int J Radiat Oncol Biol Phys2013https://conductscience.org/library/papers/23773390PubMed
1115850906Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/15850906PubMed
1210235156Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.JAMA1999https://conductscience.org/library/papers/10235156PubMed
1320009774Impact of postoperative radiation after esophagectomy for esophageal cancer.J Thorac Oncol2010https://conductscience.org/library/papers/20009774PubMed
141925862
Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research.
Surg Gynecol Obstet1991https://conductscience.org/library/papers/1925862PubMed
1524399786Cancer statistics, 2014.CA Cancer J Clin2014https://conductscience.org/library/papers/24399786PubMed
1622646630Preoperative chemoradiotherapy for esophageal or junctional cancer.N Engl J Med2012https://conductscience.org/library/papers/22646630PubMed
1719622256The management of a patient with an operable carcinoma of the oesophagus.Ann R Coll Surg Engl2009https://conductscience.org/library/papers/19622256PubMed
1820189259Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases.Radiother Oncol2010https://conductscience.org/library/papers/20189259PubMed
1924612702Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.Ann Thorac Surg2014https://conductscience.org/library/papers/24612702PubMed
203813689Local recurrences after subtotal esophagectomy for squamous cell carcinoma.Ann Surg1987https://conductscience.org/library/papers/3813689PubMed

See all 24 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42523699Postoperative radiotherapy for resected esophageal squamous cell carcinoma: a systematic review and meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42523699PubMed
42458490Postoperative adjuvant therapy for pT3N0M0 esophageal carcinoma: does radiotherapy offer added benefit beyond chemotherapy?Radiat Oncol2026https://conductscience.org/library/papers/42458490PubMed
40061535Radiation therapy does not improve survival in patients who are upstaged after esophagectomy for clinical early-stage esophageal adenocarcinoma.JTCVS Open2025https://conductscience.org/library/papers/40061535PubMed
39472872Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy.BMC Cancer2024https://conductscience.org/library/papers/39472872PubMed
39259654Postoperative Radiotherapy in Curatively Resected Esophageal Squamous Cell Carcinoma With Occult Recurrent Laryngeal Nerve Lymph Node Metastasis.Cancer Control2024https://conductscience.org/library/papers/39259654PubMed
38627783A approach of gastric conduit via the anterior of pulmonary hilum route during minimally invasive McKeown esophagectomy.J Cardiothorac Surg2024https://conductscience.org/library/papers/38627783PubMed
38365822Dual-energy computed tomography in the early evaluation of acute radiation pneumonia.Eur J Med Res2024https://conductscience.org/library/papers/38365822PubMed
37184977Association of survival with adjuvant radiotherapy for pN0 esophageal cancer.Aging (Albany NY)2023https://conductscience.org/library/papers/37184977PubMed
36185174No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis.Front Oncol2022https://conductscience.org/library/papers/36185174PubMed
36117831Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer.Front Surg2022https://conductscience.org/library/papers/36117831PubMed
33933129Survival risk prediction model for patients with pT1-3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes.J Cardiothorac Surg2021https://conductscience.org/library/papers/33933129PubMed
33290111Risk factors for tumor recurrence in patients with pT3N0M0 thoracic esophageal squamous cell carcinoma after esophagectomy.J Int Med Res2020https://conductscience.org/library/papers/33290111PubMed
31828980Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis.Thorac Cancer2020https://conductscience.org/library/papers/31828980PubMed
30881419Effects of lymph node metastasis of thoracic esophageal squamous cell carcinoma on design of radiotherapy target volume.Pak J Med Sci2019https://conductscience.org/library/papers/30881419PubMed
30461614Comparison of the effect of postoperative radiotherapy with surgery alone for esophagus squamous cell carcinoma patients: A meta-analysis.Medicine (Baltimore)2018https://conductscience.org/library/papers/30461614PubMed
30174889The role of postoperative radiotherapy for radically resected esophageal squamous cell carcinoma: a systemic review and meta-analysis.J Thorac Dis2018https://conductscience.org/library/papers/30174889PubMed
27822478Comparison and Prognostic Analysis of Adjuvant Radiotherapy versus Salvage Radiotherapy for Treatment of Radically Resected Locally Advanced Esophageal Squamous Cell Carcinoma.Biomed Res Int2016https://conductscience.org/library/papers/27822478PubMed
27639386Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma-a review.Tumour Biol2016https://conductscience.org/library/papers/27639386PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26328915

GET https://conductscience.org/api/papers/v1/26328915/references?page=2